Evidence map›Paper›PMID 36693871›Full record

ArticleNature communications2023

3D RNA-scaffolded wireframe origami.

Molly F Parsons, Matthew F Allan, Shanshan Li, Tyson R Shepherd, Sakul Ratanalert, Kaiming Zhang, Krista M Pullen, Wah Chiu, Silvi Rouskin, Mark Bathe

Abstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Switchback RNA.ACS chemical biology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. 2D-nanomaterials for AKI treatment.Frontiers in bioengineering and biotechnology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Molly F Parsons *Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.ORCID 0000-0003-0370-8162
Matthew F Allan *Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Shanshan Li *Department of Bioengineering, Stanford University, Stanford, CA, 94305, USA.ORCID 0000-0002-7041-5960
Tyson R ShepherdDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Sakul RatanalertDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.ORCID 0000-0002-1766-807X
Kaiming ZhangDepartment of Bioengineering, Stanford University, Stanford, CA, 94305, USA.
Krista M PullenDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.ORCID 0000-0002-4857-8907
Wah ChiuDepartment of Bioengineering, Stanford University, Stanford, CA, 94305, USA.ORCID 0000-0002-8910-3078
Silvi RouskinDepartment of Microbiology, Harvard Medical School, Boston, MA, USA.
Mark BatheDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA. mark.bathe@mit.edu.ORCID 0000-0002-6199-6855

Funding

TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YAFFE, MICHAEL B · 1985 to 2020
$25.6M
Resource for Biocomputing Visualization and InformaticsP41GM103311 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2012 to 2017
$8.2M
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
Structured DNA Nanoparticles Therapeutic mRNA and CRISPR/Cas9 DeliveryR21EB026008 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BATHE, MARK · 2018 to 2021
$796k
NIBIB NIH HHS R21 EB026008NIEHS NIH HHS P30 ES002109NIGMS NIH HHS P41 GM103311NIGMS NIH HHS R01 GM129325
6 · The paper itself

Abstract

Hybrid RNA:DNA origami, in which a long RNA scaffold strand folds into a target nanostructure via thermal annealing with complementary DNA oligos, has only been explored to a limited extent despite its unique potential for biomedical delivery of mRNA, tertiary structure characterization of long RNAs, and fabrication of artificial ribozymes. Here, we investigate design principles of three-dimensional wireframe RNA-scaffolded origami rendered as polyhedra composed of dual-duplex edges. We computationally design, fabricate, and characterize tetrahedra folded from an EGFP-encoding messenger RNA and de Bruijn sequences, an octahedron folded with M13 transcript RNA, and an octahedron and pentagonal bipyramids folded with 23S ribosomal RNA, demonstrating the ability to make diverse polyhedral shapes with distinct structural and functional RNA scaffolds. We characterize secondary and tertiary structures using dimethyl sulfate mutational profiling and cryo-electron microscopy, revealing insight into both global and local, base-level structures of origami. Our top-down sequence design strategy enables the use of long RNAs as functional scaffolds for complex wireframe origami.

Indexed as

NanostructuresNanotechnologyCryoelectron MicroscopyNucleic Acid ConformationRNARNA, MessengerRNARNA, Messenger

Identifiers

PMID36693871
PMCPMC9872083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.